Analysis Group Hosts 2024 Health Care and Life Sciences Litigation Practice Day

July 25, 2024

More than 80 Analysis Group consultants convened in Boston this summer for a day of presentations and discussions of current challenges and future trends in health care and life sciences litigation. Several topics were explored, including developments in economic issues in intellectual property (IP) cases involving biosimilars and biologics; the assessment and use of claims data collected from payers, pharmacy benefit managers (PBMs), and the government; notable decisions in non-pharmaceutical merger cases; and key takeaways from recent court rulings on expert testimony.

Following these presentations, several of the firm’s consultants participated in a mock trial focused on causation and damages associated with a case involving alleged violations of the False Claims Act and Anti-Kickback Statute through payments made to health care providers for their participation in a speaker program.

Read more about our Health Care and Life Sciences Litigation services